Genomic Analysis of Kidney Allograft Injury Identifies Hematopoietic Cell Kinase as a Key Driver of Renal Fibrosis

J Am Soc Nephrol. 2017 May;28(5):1385-1393. doi: 10.1681/ASN.2016020238. Epub 2016 Dec 7.

Abstract

Renal fibrosis is the common pathway of progression for patients with CKD and chronic renal allograft injury (CAI), but the underlying mechanisms remain obscure. We performed a meta-analysis in human kidney biopsy specimens with CAI, incorporating data available publicly and from our Genomics of Chronic Renal Allograft Rejection study. We identified an Src family tyrosine kinase, hematopoietic cell kinase (Hck), as upregulated in allografts in CAI. Querying the Kinase Inhibitor Resource database revealed that dasatinib, a Food and Drug Administration-approved drug, potently binds Hck with high selectivity. In vitro, Hck overexpression activated the TGF-β/Smad3 pathway, whereas HCK knockdown inhibited it. Treatment of tubular cells with dasatinib reduced the expression of Col1a1 Dasatinib also reduced proliferation and α-SMA expression in fibroblasts. In a murine model with unilateral ureteric obstruction, pretreatment with dasatinib significantly reduced the upregulation of profibrotic markers, phosphorylation of Smad3, and renal fibrosis observed in kidneys pretreated with vehicle alone. Dasatinib treatment also improved renal function, reduced albuminuria, and inhibited expression of profibrotic markers in animal models with lupus nephritis and folic acid nephropathy. These data suggest that Hck is a key mediator of renal fibrosis and dasatinib could be developed as an antifibrotic drug.

Keywords: Hck; chronic renal allograft injury; dasatinib; renal fibrosis.

Publication types

  • Meta-Analysis

MeSH terms

  • Animals
  • Female
  • Fibrosis / genetics
  • Genomics
  • Humans
  • Kidney / pathology*
  • Kidney Diseases / genetics*
  • Kidney Transplantation*
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Postoperative Complications / genetics*
  • Proto-Oncogene Proteins c-hck / genetics*
  • Proto-Oncogene Proteins c-hck / physiology*

Substances

  • Hck protein, mouse
  • Proto-Oncogene Proteins c-hck